- 2019 - 2022 Stratification of late onset psychosis using imaging biomarkers
- 2017 - 2020 Evaluation of tau accumulation with PBB3-PET in amyloid negative dementia patients
- 2016 - 2020 Etiological assessments of neurodegenerative dementias by in-vivo imaging of pathological protein aggregates in the brain
- 2015 - 2018 In vivo brain activity imaging in DREADD expressed animals
- 2014 - 2018 Tau PET study for revealing the pathogenesis and establishing the objective marker of disease severity in neurodegenerative dementia
- 2014 - 2018 Evaluation of tau accumulation with PBB3-PET in amyloid negative dementia patients
- 2011 - 2016 Development of ligands for early diagnosis and mechanistic controls of tauopathies
- 2011 - 2016 Molecular imaging of neurotoxic signaling in neurodegenerative disorders
- 2011 - 2016 Brain Environment
- 2012 - 2015 In vivo PET and optical imaging of neurogenesis of neuronal circuit
- 2011 - 2013 Relationship between cerebral perfusion/neuronal activity and amyloid deposition
- 2010 - 2012 Developing a new diagnostic system using positron emission tomography for dementia with Lewy bodies
- 2008 - 2010 Methodological development of quantitative tracer kinetic analysis in rodents using small animal PET.
- 2008 - 2010 Quantitative neuroreceptor imaging for mice using PET : development of micro litter ordered blood radioactivity counting system and the technique to omit arterial blood sampling
- 2008 - 2009 アミロイドカスケードのキープロセス可視化によるアルツハイマー病の診断・治療法開発
- 2007 - 2009 NMDA受容体NR2Bサブユニットを中心とした恐怖学習のメカニズム
- 2006 - 2007 アミロイドとミクログリアの生体画像化による抗アミロイド療法の機構解明と評価法確立
- 2005 - 2006 新規化合物による脳アミロイド病変形成阻害効果の解析
Show all